Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis
Stopped Study stopped due to low accrual and availability of other treatment options
Conditions
Interventions
- DRUG: Simeprivir (SMV)
- DRUG: Sofosbuvir (SOF)
- DRUG: Ribavirin (RBV)
Sponsor
University of Colorado, Denver
Collaborators